Trial Profile
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2012
Price :
$35
*
At a glance
- Drugs Daunorubicin (Primary) ; Enocitabine (Primary) ; Ubenimex (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.